in ,

Coronavirus outbreak: Artificial intelligence could help find treatment, Recode

Coronavirus outbreak: Artificial intelligence could help find treatment, Recode
  

                         Open Sourced logo           

To battle the novel coronavirus that’s been linked to Wuhan, China, researchers are using artificial intelligence to discover potential treatments, including already-approved drugs and completely new compounds. At the same time, the pneumonia-like illness has only gotten worse. As of Friday morning,

the – – nCoV coronavirus had taken the lives of more than 1101 people and infected more than , , with cases documented in (at least) countries Researchers at the British artificial intelligence startup Benevolent AI say they used the tech to search for existing approved drugs that might be helpful in limiting the virus’s infection . Another set of scientists affiliated with Deargen,

a drug discovery company based in South Korea , say that they used deep learning to find various available antiviral drugs that could be investigated as a potential treatment ( that research has not yet been peer-reviewed). Meanwhile, a Maryland-based biotech company, Insilico, said it used AI to come up with new molecules that could serve as potential medications, and it will now synthesize and test (of the compounds, according to Fortune . Here’s how Benevolent described its

work

: The company researchers wanted to find an already-approved drug that could block the infection process. So they sent their AI looking for drugs, based on chemical properties that they knew the coronavirus to have, through a repository of an enormous amount of medical data, including scientific literature.

The system churned out a number of options, which were then whittled down to identify an already-approved drug called Baricitinib

, which is typically used to treat moderate and severe rheumatoid arthritis. Now the researchers suggest it could be trialed as a potential treatment. Ivan Griffin, Benevolent’s co-founder, told Recode that while the company hasn’t applied for the right to test the drug in China, it has reached out to manufacturers that already produce the drug. It’s unclear how long it might take before a properly tested drug reaches patients.

Griffin emphasizes that his company research was conducted in a time frame that would have been “impossible to replicate” without Benevolent’s curated and wide variety of datasets and artificial intelligence. Still, that AI identified this drug is no guarantee that it’ll actually work. Benevolent also cautions that its research should not be taken as medical advice, and that its work should only be taken “in good faith and to assist in the global response.”

Baricitinib is by no means the only treatment scientists have suggested, and researchers in China have applied to test at least medications as a potential treatments,

according to the Wall Street Journal , though

none has yet been approved . Keep in mind that misinterpretations of the science about coronaviruses have exacerbated misinformation related to the novel Wuhan strain. ( You can read more here about coronavirus-related misinformation .)

The application of AI to the fight against the novel coronavirus comes as the role of the technology in health care expands. In fact, AI already helped epidemiologists flag early reports of the Wuhan coronavirus, as Recode reported last week . Ultimately, the hope is that the technology could make delivering health care more efficient. But the use of artificial intelligence in health care also creates new challenges, like

algorithmic bias

, and raises new questions for drug regulators

.

Still, pharmaceutical giants are hoping that investment in the tech will Give them a leg up in the lucrative drug discovery market. Benevolent is already working with Novartis and AstraZeneca

. Identifying a potential new treatment can be a long and expensive process that AI, they hope, can expedite.

Some have pointed out that there no guarantee That the “discoveries” AI makes will be particularly new. As Derek Lowe, a researcher at Novartis who writes about drug discovery, argued to Chemical & Engineering News , Benevolent’s findings were “more a testimony to good literature searching and curation.” But in an email to Recode, Griffin emphasizes that AI still provides an important advantage: The technology can “help our scientists uncover relationships between diseases and symptoms, drugs and their effect, the patients who might respond to treatment.” The technology, he argues, allows us to gain insights that , due to “the overwhelming volume of biomedical information,” we otherwise would miss. And when facing a life- threatening outbreak like the one we’re seeing with the novel coronavirus, it’s possible that just saving scientists some time could potentially make a world of difference. (Open Sourced) Is made possible by the Omidyar Network. All Open Sourced content is editorially independent and produced by our journalists.

(Read More) Brave Browser

What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

ICE now uses cellphone location data to help arrest immigrants, Recode

ICE now uses cellphone location data to help arrest immigrants, Recode

China takes desperate, “wartime” measures to stop coronavirus in Wuhan, Ars Technica

China takes desperate, “wartime” measures to stop coronavirus in Wuhan, Ars Technica